{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:53:56Z","timestamp":1787500436185,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00464-021-08543-6","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T19:10:18Z","timestamp":1621365018000},"page":"2554-2563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fundoplication is superior to medical therapy for Barrett\u2019s esophagus disease regression and progression: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"H.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-6242","authenticated-orcid":false,"given":"V.","family":"Mocanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Jogiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Switzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Karmali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"8543_CR1","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","volume":"365","author":"F Hvid-Jensen","year":"2011","unstructured":"Hvid-Jensen F, Pedersen L, Drewes AM, S\u00f8rensen HT, Funch-Jensen P (2011) Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus. N Engl J Med 365:1375\u20131383. https:\/\/doi.org\/10.1056\/NEJMoa1103042","journal-title":"N Engl J Med"},{"key":"8543_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doaa115","author":"I Marques de S\u00e1","year":"2020","unstructured":"Marques de S\u00e1 I, Pereira AD, Sharma P, Dinis-Ribeiro M (2020) Systematic review of the published guidelines on Barrett\u2019s esophagus: should we stress the consensus or the differences? Dis esophagus Off J Int Soc Dis Esophagus. https:\/\/doi.org\/10.1093\/dote\/doaa115","journal-title":"Dis esophagus Off J Int Soc Dis Esophagus"},{"key":"8543_CR3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.cgh.2015.12.027","volume":"14","author":"C Kestens","year":"2016","unstructured":"Kestens C, Offerhaus GJA, van Baal JWPM, Siersema PD (2016) Patients with Barrett\u2019s esophagus and persistent low-grade dysplasia have an increased risk for high-grade dysplasia and cancer. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 14:956-962.e1. https:\/\/doi.org\/10.1016\/j.cgh.2015.12.027","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"8543_CR4","unstructured":"Canadian Cancer Society (2019) Survival Statistics for Esophageal Cancer. Available at https:\/\/www.cancer.ca\/en\/cancer-information\/cancer-type\/esophageal\/prognosis-and-survival\/survival-statistics\/?region=qc. Accessed 16 Jan 2020"},{"key":"8543_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.gtc.2015.02.001","volume":"44","author":"TM Runge","year":"2015","unstructured":"Runge TM, Abrams JA, Shaheen NJ (2015) Epidemiology of Barrett\u2019s esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 44:203\u2013231. https:\/\/doi.org\/10.1016\/j.gtc.2015.02.001","journal-title":"Gastroenterol Clin North Am"},{"key":"8543_CR6","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1001\/jama.2020.21360","volume":"324","author":"J Maret-Ouda","year":"2020","unstructured":"Maret-Ouda J, Markar SR, Lagergren J (2020) Gastroesophageal reflux disease: a review. JAMA 324:2536\u20132547. https:\/\/doi.org\/10.1001\/jama.2020.21360","journal-title":"JAMA"},{"key":"8543_CR7","unstructured":"Society of American Gastrointestinal and Endoscopic Surgeons (2020) Survival Statistics for Esophageal Cancer. https:\/\/www.sages.org\/publications\/guidelines\/guidelines-for-surgical-treatment-of-gastroesophageal-reflux-disease-gerd\/. Accessed 3 Dec 2020"},{"key":"8543_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00268-007-9409-4","volume":"32","author":"SEA Attwood","year":"2008","unstructured":"Attwood SEA, Lundell L, Ell C, Galmiche J-P, Hatlebakk J, Fiocca R, Lind T, Eklund S, Junghard O (2008) Standardization of surgical technique in antireflux surgery: the LOTUS trial experience. World J Surg 32:995\u2013998. https:\/\/doi.org\/10.1007\/s00268-007-9409-4","journal-title":"World J Surg"},{"key":"8543_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/SLA.0000000000001438","volume":"263","author":"J Maret-Ouda","year":"2016","unstructured":"Maret-Ouda J, Konings P, Lagergren J, Brusselaers N (2016) Antireflux surgery and risk of esophageal adenocarcinoma: a systematic review and meta-analysis. Ann Surg 263:251\u2013257. https:\/\/doi.org\/10.1097\/SLA.0000000000001438","journal-title":"Ann Surg"},{"key":"8543_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138237","author":"NR Haddaway","year":"2015","unstructured":"Haddaway NR, Collins AM, Coughlin DKS (2015) The role of google scholar in evidence reviews and its applicability to grey literature searching. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0138237","journal-title":"PLoS ONE"},{"key":"8543_CR11","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2020) Cochrane handbook for systematic reviews of interventions version 6.1. Available at www.training.cochrane.org\/handbook. Accessed 15 Dec 2020","DOI":"10.1002\/9781119536604"},{"key":"8543_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"8543_CR13","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/bjs.1800791021","volume":"79","author":"SE Attwood","year":"1992","unstructured":"Attwood SE, Barlow AP, Norris TL, Watson A (1992) Barrett\u2019s oesophagus: effect of antireflux surgery on symptom control and development of complications. Br J Surg 79:1050\u20131053. https:\/\/doi.org\/10.1002\/bjs.1800791021","journal-title":"Br J Surg"},{"key":"8543_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1072-7515(03)00147-9","volume":"196","author":"RR Gurski","year":"2003","unstructured":"Gurski RR, Peters JH, Hagen JA, DeMeester SR, Bremner CG, Chandrasoma PT, DeMeester TR (2003) Barrett\u2019s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg 196:703\u2013706. https:\/\/doi.org\/10.1016\/S1072-7515(03)00147-9","journal-title":"J Am Coll Surg"},{"key":"8543_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/SLA.0000000000002890","volume":"268","author":"SR Markar","year":"2018","unstructured":"Markar SR, Arhi C, Leusink A, Vidal-Diez A, Karthikesalingam A, Darzi A, Lagergren J, Hanna GB (2018) The influence of antireflux surgery on esophageal cancer risk in England: national population-based cohort study. Ann Surg 268:861\u2013867. https:\/\/doi.org\/10.1097\/SLA.0000000000002890","journal-title":"Ann Surg"},{"key":"8543_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/01.sla.0000167864.46462.9f","volume":"242","author":"S Oberg","year":"2005","unstructured":"Oberg S, Wenner J, Johansson J, Walther B, Will\u00e9n R (2005) Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 242:49\u201354. https:\/\/doi.org\/10.1097\/01.sla.0000167864.46462.9f","journal-title":"Ann Surg"},{"key":"8543_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/01.SLA.0000055269.77838.8E","volume":"237","author":"P Parrilla","year":"2003","unstructured":"Parrilla P, Mart\u00ednez de Haro LF, Ortiz A, Munitiz V, Molina J, Bermejo J, Canteras M (2003) Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett\u2019s esophagus. Ann Surg 237:291\u2013298. https:\/\/doi.org\/10.1097\/01.SLA.0000055269.77838.8E","journal-title":"Ann Surg"},{"key":"8543_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/01.sla.0000194085.56699.db","volume":"243","author":"M Rossi","year":"2006","unstructured":"Rossi M, Barreca M, de Bortoli N, Renzi C, Santi S, Gennai A, Bellini M, Costa F, Conio M, Marchi S (2006) Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg 243:58\u201363. https:\/\/doi.org\/10.1097\/01.sla.0000194085.56699.db","journal-title":"Ann Surg"},{"key":"8543_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/dote\/3.1.29","volume":"3","author":"MDP Trentino","year":"1990","unstructured":"Trentino MDP, Trifero MDM, Marzullo MDA, Arcese MDR, Correnti MDFS, Pappalardo MDG, Castrini MDG (1990) Biomarkers\u2019 evaluation for early neoplastic degeneration in Barrett\u2019s esophagus. A preliminary report on 12 cases. Dis Esophagus 3:29\u201336. https:\/\/doi.org\/10.1093\/dote\/3.1.29","journal-title":"Dis Esophagus"},{"key":"8543_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s00464-014-3713-5","volume":"29","author":"S Tolone","year":"2015","unstructured":"Tolone S, Limongelli P, Romano M, Federico A, Docimo G, Ruggiero R, Brusciano L, Del Genio G, Docimo L (2015) The patterns of reflux can affect regression of non-dysplastic and low-grade dysplastic Barrett\u2019s esophagus after medical and surgical treatment: a prospective case-control study. Surg Endosc 29:648\u2013657. https:\/\/doi.org\/10.1007\/s00464-014-3713-5","journal-title":"Surg Endosc"},{"key":"8543_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11605-011-1739-8","volume":"16","author":"G Zaninotto","year":"2012","unstructured":"Zaninotto G, Parente P, Salvador R, Farinati F, Tieppo C, Passuello N, Zanatta L, Fassan M, Cavallin F, Costantini M, Mescoli C, Battaglia G, Ruol A, Ancona E, Rugge M (2012) Long-term follow-up of Barrett\u2019s epithelium: medical versus antireflux surgical therapy. J Gastrointest Surg Off J Soc Surg Aliment Tract 16:5\u20137. https:\/\/doi.org\/10.1007\/s11605-011-1739-8","journal-title":"J Gastrointest Surg Off J Soc Surg Aliment Tract"},{"key":"8543_CR22","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1053\/j.gastro.2011.01.031","volume":"140","author":"SJ Spechler","year":"2011","unstructured":"Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ, Association AG (2011) American gastroenterological association technical review on the management of Barrett\u2019s esophagus. Gastroenterol 140:e18\u2013e13. https:\/\/doi.org\/10.1053\/j.gastro.2011.01.031","journal-title":"Gastroenterol"},{"key":"8543_CR23","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.3748\/wjg.v16.i30.3762","volume":"16","author":"DS Oh","year":"2010","unstructured":"Oh DS, Demeester SR (2010) Pathophysiology and treatment of Barrett\u2019s esophagus. World J Gastroenterol 16:3762\u20133772. https:\/\/doi.org\/10.3748\/wjg.v16.i30.3762","journal-title":"World J Gastroenterol"},{"key":"8543_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1572-0241.2003.04018.x","volume":"99","author":"NA Tobey","year":"2004","unstructured":"Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC (2004) Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol 99:13\u201322. https:\/\/doi.org\/10.1046\/j.1572-0241.2003.04018.x","journal-title":"Am J Gastroenterol"},{"key":"8543_CR25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/00000658-199710000-00013","volume":"226","author":"S Oberg","year":"1997","unstructured":"Oberg S, Peters JH, DeMeester TR, Chandrasoma P, Hagen JA, Ireland AP, Ritter MP, Mason RJ, Crookes P, Bremner CG (1997) Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 226:522\u2013532. https:\/\/doi.org\/10.1097\/00000658-199710000-00013","journal-title":"Ann Surg"},{"key":"8543_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.surg.2011.08.021","volume":"151","author":"AO Nasr","year":"2012","unstructured":"Nasr AO, Dillon MF, Conlon S, Downey P, Chen G, Ireland A, Leen E, Bouchier-Hayes D, Walsh TN (2012) Acid suppression increases rates of Barrett\u2019s esophagus and esophageal injury in the presence of duodenal reflux. Surgery 151:382\u2013390. https:\/\/doi.org\/10.1016\/j.surg.2011.08.021","journal-title":"Surgery"},{"key":"8543_CR27","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1055\/s-0032-1312922","volume":"50","author":"S J\u00fcrgens","year":"2012","unstructured":"J\u00fcrgens S, Meyer F, Spechler SJ, Souza R (2012) The role of bile acids in the neoplastic progression of Barrett\u2019s esophagus - a short representative overview. Z Gastroenterol 50:1028\u20131034. https:\/\/doi.org\/10.1055\/s-0032-1312922","journal-title":"Z Gastroenterol"},{"key":"8543_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/00000658-199522240-00010","volume":"222","author":"WK Kauer","year":"1995","unstructured":"Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA (1995) Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 222:525\u2013533. https:\/\/doi.org\/10.1097\/00000658-199522240-00010","journal-title":"Ann Surg"},{"key":"8543_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S1091-255X(98)80072-3","volume":"2","author":"HJ Stein","year":"1998","unstructured":"Stein HJ, Kauer WKH, Feussner H, Siewert JR (1998) Bile reflux in benign and malignant Barrett\u2019s esophagus: effect of medical acid suppression and Nissen fundoplication. J Gastrointest Surg 2:333\u2013341. https:\/\/doi.org\/10.1016\/S1091-255X(98)80072-3","journal-title":"J Gastrointest Surg"},{"key":"8543_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jamcollsurg.2012.03.022","volume":"215","author":"S Niebisch","year":"2012","unstructured":"Niebisch S, Fleming FJ, Galey KM, Wilshire CL, Jones CE, Litle VR, Watson TJ, Peters JH (2012) Perioperative risk of laparoscopic fundoplication: safer than previously reported\u2014analysis of the American college of surgeons national surgical quality improvement program 2005 to 2009. JACS 215:61\u201368. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2012.03.022","journal-title":"JACS"},{"key":"8543_CR31","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1111\/j.1572-0241.1999.01277.x","volume":"94","author":"AJ Cameron","year":"1999","unstructured":"Cameron AJ (1999) Barrett\u2019s esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 94:2054\u20132059. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01277.x","journal-title":"Am J Gastroenterol"},{"key":"8543_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bpg.2014.11.002","volume":"29","author":"S Roman","year":"2015","unstructured":"Roman S, Kahrilas PJ (2015) Mechanisms of Barrett\u2019s oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects. Best Pract Res Clin Gastroenterol 29:17\u201328. https:\/\/doi.org\/10.1016\/j.bpg.2014.11.002","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"8543_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2036.2006.02982.x","volume":"24","author":"EM Van Soest","year":"2006","unstructured":"Van Soest EM, Siersema PD, Dieleman JP, Sturkenboom MCJM, Kuipers EJ (2006) Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 24:377\u2013385. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.02982.x","journal-title":"Aliment Pharmacol Ther"},{"key":"8543_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cgh.2011.07.008","volume":"10","author":"APS Hungin","year":"2012","unstructured":"Hungin APS, Hill C, Molloy-Bland M, Raghunath A (2012) Systematic review: patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 10:109\u2013116. https:\/\/doi.org\/10.1016\/j.cgh.2011.07.008","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"8543_CR35","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1038\/ajg.2009.312","volume":"104","author":"HB El-Serag","year":"2009","unstructured":"El-Serag HB, Fitzgerald S, Richardson P (2009) The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. Am J Gastroenterol 104:2161\u20132167. https:\/\/doi.org\/10.1038\/ajg.2009.312","journal-title":"Am J Gastroenterol"},{"key":"8543_CR36","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1111\/j.1572-0241.2003.08702.x","volume":"98","author":"KE Corey","year":"2003","unstructured":"Corey KE, Schmitz SM, Shaheen NJ (2003) Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett\u2019s esophagus? A meta-analysis. Am J Gastroenterol 98:2390\u20132394. https:\/\/doi.org\/10.1111\/j.1572-0241.2003.08702.x","journal-title":"Am J Gastroenterol"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-021-08543-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-021-08543-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-021-08543-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T11:17:29Z","timestamp":1647256649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-021-08543-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["8543"],"URL":"https:\/\/doi.org\/10.1007\/s00464-021-08543-6","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"20 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ms. Wilson and Kung, and Drs. Mocanu, Sun, Deng, Jogiat, Switzer, Wong and Karmali have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}